Oppenheimer analyst Leland Gershall reiterated an Outperform rating and $14.00 price target on CalciMedica (NASDAQ: CALC).The analyst commented: "Yesterday's positive ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE